Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Receivables (2023 - 2025)

Historic Change in Receivables for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $3.4 million.

  • Profound Medical's Change in Receivables fell 5224.75% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 7862.02%. This contributed to the annual value of -$186000.0 for FY2024, which is 10255.21% down from last year.
  • As of Q3 2025, Profound Medical's Change in Receivables stood at $3.4 million, which was down 5224.75% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Change in Receivables ranged from a high of $7.0 billion in Q1 2023 and a low of -$1.4 million during Q2 2025
  • Its 3-year average for Change in Receivables is $639.2 million, with a median of $6.5 million in 2024.
  • As far as peak fluctuations go, Profound Medical's Change in Receivables skyrocketed by 874.58% in 2024, and later tumbled by 11897.51% in 2025.
  • Over the past 3 years, Profound Medical's Change in Receivables (Quarter) stood at $1.1 million in 2023, then plummeted by 46.44% to $595000.0 in 2024, then skyrocketed by 464.2% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, -$1.4 million for Q2 2025, and -$1.1 million during Q1 2025.